Harvard Bioscience
Open
$6.33
Prev. Close
$6.33
High
$6.33
Low
$6.33
Market Snapshot
$27.19M
-2.8
-0.28
$94.14M
328
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 316 full-time employees. The company went IPO on 2013-10-21. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 316 full-time employees. The company went IPO on 2013-10-21. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Recently from Cashu
Harvard Bioscience Analyzes Earnings Trends to Strengthen Market Position and Innovate Research Tools
Harvard Bioscience Leverages Earnings Reports to Enhance Market Position Harvard Bioscience, a leader in the life sciences tools market, focuses on developing and commercializing innovative products t…
Sure! Please provide the content you'd like summarized, and I'll create a title for you.
Sure! Please provide the content or key points you'd like summarized, and I’ll create a summary based on that information.
Please provide the specific content you'd like summarized regarding Harvard Bioscience.
Unfortunately, you haven’t provided the specific text or content about Harvard Bioscience that you would like summarized. If you can share that information with me, I'll be able to create the article…
Harvard Bioscience and Ethical Leadership: Fallout from Larry Summers' Epstein Controversy
Larry Summers Steps Back Amid Epstein Controversy: Implications for Academia Former Treasury Secretary Larry Summers announces his intention to step back from public commitments in light of recent rev…